Fund Holdings — Deep Track Capital, LP

Total Portfolio Value:
$2.67B
Total Bought:
$816.12M
Total Sold:
$1.25B
Net Transaction:
-$431.23M
Securities
▲▼
SharesValue
Q3 2024
▲▼
Q4 2024
▲▼
Change
▲▼
Q3 2024
▲▼
Q4 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Dynavax Technologies Corp12,526,48617,791,486+5,265,000$139.55M$227.20M8.52%+$87.65M
Guardant Health, Inc.(GH)6,000,5606,419,566+419,006$137.65M$196.12M7.35%+$58.46M
Intra-Cellular Therapies Inc1,600,6932,000,000+399,307$117.12M$167.04M6.26%+$49.92M
Immunovant, Inc.(IMVT)4,347,4646,000,000+1,652,536$123.95M$148.62M5.57%+$24.67M
Apellis Pharmaceuticals Inc
COM
4,400,6544,274,921-125,733$126.91M$136.41M5.11%+$9.50M
Springworks Therapeutics Inc3,843,9003,460,756-383,144$123.16M$125.04M4.69%+$1.88M
Cytokinetics, Incorporated(CYTK)629,9062,500,000+1,870,094$33.26M$117.60M4.41%+$84.34M
Ocular Therapeutix, Inc.(OCUL)12,721,46012,836,282+114,822$110.68M$109.62M4.11%-$1.05M
Viridian Therapeutics, Inc.(VRDN)3,750,9454,522,741+771,796$85.33M$86.70M3.25%+$1.37M
Pliant Therapeutics, Inc.(PLRX)5,972,2575,972,2570$66.95M$78.65M2.95%+$11.71M
Structure Therapeutics IncADS1,220,5082,800,000+1,579,492$53.57M$75.94M2.85%+$22.37M
Ionis Pharmaceuticals, Inc.(IONS)2,200,0001,933,928-266,072$88.13M$67.61M2.53%-$20.52M
Nurix Therapeutics, Inc.(NRIX)3,868,1043,000,000-868,104$86.92M$56.52M2.12%-$30.40M
MBX Biosciences, Inc.(MBX)3,018,9353,018,9350$78.43M$55.64M2.09%-$22.79M
89bio Inc2,766,5126,478,249+3,711,737$20.47M$50.66M1.90%+$30.19M
Harmony Biosciences Holdings, Inc.(HRMY)01,450,000+1,450,000$0$49.89M1.87%+$49.89M
Dyne Therapeutics, Inc.(DYN)3,282,0002,000,000-1,282,000$117.89M$47.12M1.77%-$70.77M
Septerna, Inc.(SEPN)01,912,929+1,912,929$0$43.81M1.64%+$43.81M
Neumora Therapeutics, Inc.(NMRA)567,4284,000,000+3,432,572$7.50M$42.40M1.59%+$34.90M
Genmab A/SADS(GMAB)02,000,000+2,000,000$0$41.74M1.56%+$41.74M
Akero Therapeutics Inc689,7841,490,000+800,216$19.79M$41.45M1.55%+$21.66M
Verona Pharma PlcADS3,180,025850,000-2,330,025$91.49M$39.47M1.48%-$52.02M
Celldex Therapeutics, Inc.(CLDX)01,540,132+1,540,132$0$38.92M1.46%+$38.92M
Protagonist Therapeutics Inc01,000,000+1,000,000$0$38.60M1.45%+$38.60M
ANI Pharmaceuticals, Inc.(ANIP)504,828649,042+144,214$30.12M$35.88M1.35%+$5.76M
Bicara Therapeutics Inc796,8522,000,000+1,203,148$20.30M$34.84M1.31%+$14.54M
Autolus Therapeutics plcADS(AUTL)15,272,17214,218,903-1,053,269$55.44M$33.41M1.25%-$22.02M
Korro Bio, Inc.(KRRO)850,000874,614+24,614$28.41M$33.30M1.25%+$4.89M
Terns Pharmaceuticals Inc5,576,5585,576,5580$46.51M$30.89M1.16%-$15.61M
Engene Holdings Inc
COM
2,607,6334,557,575+1,949,942$17.21M$30.31M1.14%+$13.10M
Ultragenyx Pharmaceutical Inc.(RARE)0653,513+653,513$0$27.49M1.03%+$27.49M
ABIVAX Société AnonymeADS(ABVX)3,579,2093,579,2090$41.23M$26.20M0.98%-$15.03M
Centessa Pharmaceuticals PlcADS1,350,0001,350,0000$21.59M$22.61M0.85%+$1.03M
BridgeBio Pharma, Inc.(BBIO)0819,162+819,162$0$22.48M0.84%+$22.48M
Lakefront Biotherapeutics NVADR(LKFT)0780,778+780,778$0$21.47M0.81%+$21.47M
Olema Pharmaceuticals, Inc.(OLMA)4,000,0003,442,833-557,167$47.76M$20.07M0.75%-$27.69M
Mind Medicine Mindmed Inc7,065,0992,816,594-4,248,505$40.20M$19.60M0.73%-$20.60M
Edgewise Therapeutics, Inc.(EWTX)1,100,536710,421-390,115$29.37M$18.97M0.71%-$10.41M
Bicycle Therapeutics PlcADS3,548,0011,276,081-2,271,920$80.29M$17.87M0.67%-$62.43M
Upstream Bio, Inc.(UPB)01,000,000+1,000,000$0$16.44M0.62%+$16.44M
Novavax, Inc.(NVAX)02,000,000+2,000,000$0$16.08M0.60%+$16.08M
Immunocore Holdings plcADS(IMCR)0519,376+519,376$0$15.32M0.57%+$15.32M
Oruka Therapeutics, Inc.(ORKA)1,235,187750,000-485,187$30.27M$14.54M0.55%-$15.73M
Geron Corporation(GERN)7,575,0494,011,287-3,563,762$34.39M$14.20M0.53%-$20.19M
Cybin D/B/A Helus Pharma(HELP)1,529,9871,529,9870$13.60M$13.49M0.51%-$107.1K
Xencor, Inc.(XNCR)800,000500,000-300,000$16.09M$11.49M0.43%-$4.60M
Aligos Therapeutics, Inc.(ALGS)244,110244,1100$2.11M$9.73M0.36%+$7.61M
Rapt Therapeutics Inc06,011,380+6,011,380$0$9.50M0.36%+$9.50M
Zura Bio LimitedCL A(ZURA)3,283,7833,283,7830$13.33M$8.21M0.31%-$5.12M
Context Therapeutics Inc.(CNTX)7,419,3557,419,3550$14.54M$7.79M0.29%-$6.75M
Allakos Inc5,000,0005,704,282+704,282$3.27M$6.90M0.26%+$3.64M
Xenon Pharmaceuticals Inc.(XENE)0169,132+169,132$0$6.63M0.25%+$6.63M
Avalo Therapeutics, Inc.(AVTX)967,000867,000-100,000$9.19M$6.44M0.24%-$2.74M
Inovio Pharmaceuticals, Inc.(INO)1,804,3663,119,162+1,314,796$10.43M$5.71M0.21%-$4.72M
Regulus Therapeutics Inc3,262,5643,262,5640$5.12M$5.15M0.19%+$32.6K
Spyre Therapeutics, Inc.(SYRE)1,000,000219,015-780,985$29.41M$5.10M0.19%-$24.31M
Invivyd, Inc.(IVVD)10,953,93710,689,603-264,334$11.17M$4.74M0.18%-$6.44M
OnKure Therapeutics, Inc.CL A(OKUR)0523,989+523,989$0$4.51M0.17%+$4.51M
4d Molecular Therapeutics In4,096,452609,900-3,486,552$44.28M$3.40M0.13%-$40.89M
Climb Bio, Inc.(CLYM)2,169,1431,040,115-1,129,028$11.04M$1.87M0.07%-$9.17M
Nektar Therapeutics(NKTR)15,922,6551,975,998-13,946,657$20.70M$1.84M0.07%-$18.86M
Alector Inc4,631,9980-4,631,998$21.59M$0—-$21.59M
Alkermes plcSHS(ALKS)3,500,0000-3,500,000$97.97M$0—-$97.97M
Alto Neuroscience, Inc.(ANRO)219,6480-219,648$2.51M$0—-$2.51M
Apogee Therapeutics Inc1,000,0000-1,000,000$58.74M$0—-$58.74M
argenx SEADR(ARGX)365,0000-365,000$197.86M$0—-$197.86M
Avidity Biosciences Inc475,0000-475,000$21.82M$0—-$21.82M
Axsome Therapeutics, Inc.(AXSM)857,2190-857,219$77.04M$0—-$77.04M
Editas Medicine, Inc.(EDIT)4,900,3340-4,900,334$16.71M$0—-$16.71M
Fate Therapeutics, Inc.(FATE)5,572,6070-5,572,607$19.50M$0—-$19.50M
Intellia Therapeutics, Inc.(NTLA)4,950,0000-4,950,000$101.72M$0—-$101.72M
Kura Oncology, Inc.(KURA)1,963,5050-1,963,505$38.37M$0—-$38.37M
Kymera Therapeutics, Inc.(KYMR)600,3260-600,326$28.41M$0—-$28.41M
Metagenomi Therapeutics, Inc.(MGX)307,5000-307,500$667.3K$0—-$667.3K
Prothena Corp PlcSHS
SHS
140,0000-140,000$2.34M$0—-$2.34M
Pyxis Oncology, Inc.(PYXS)4,184,1000-4,184,100$15.36M$0—-$15.36M
Relmada Therapeutics, Inc.(RLMD)674,8330-674,833$2.19M$0—-$2.19M
Scholar Rock Holding Corporation(SRRK)48,1000-48,100$385.3K$0—-$385.3K
Silence Therapeutics plcADS(SLN)1,000,0000-1,000,000$18.18M$0—-$18.18M
Syros Pharmaceuticals Inc828,4850-828,485$1.78M$0—-$1.78M
TG Therapeutics, Inc.(TGTX)1,725,0000-1,725,000$40.35M$0—-$40.35M
Travere Therapeutics, Inc.(TVTX)531,8570-531,857$7.44M$0—-$7.44M
Vigil Neuroscience Inc1,553,9960-1,553,996$5.28M$0—-$5.28M
Page 1 of 1
Deep Track Capital, LP — 13F Holdings — Q4 2024 | TickerTrail